Pancreatic adenocarcinoma remains one of the most aggressive and difficult-to-treat solid tumor malignancies, with a high mortality-to-incidence ratio. Globally, pancreatic cancer ranks 12th in terms ...

33 months after the original course of treatment. Autopsy demonstrated extensive metastatic carcinoma of the endometrium, with metastases to the para-aortic lymph nodes, vertebras, kidneys and ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with more than one million new diagnoses annually.

The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...

It also helps your doctor decide on the best treatments. If your doctor thinks you might have adenoid cystic carcinoma, they'll often get a biopsy. A biopsy tests a small tissue sample of your tumor.

Use code FY25SAVE at checkout. A recent market review shows that the pancreatic adenocarcinoma treatment market size has demonstrated rapid growth in recent years. The market size is projected to ...